John Hopkins University and Ajit Isaac Foundation to establish 63-bed Palliative Care Centre in Tumkur

Johns Hopkins University and the Ajit Isaac Foundation partnered to establish palliative care centers in underserved areas of India. The collaboration will focus on training caregivers, developing curriculum, and offering mentorship to improve end-of-life care for terminally ill patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4DPi9tI
via IFTTT

Read More

Festivity and diabetes: a guide to healthy indulgences and guilt-free joy!

Diwali and the Indian wedding season, while joyous, pose a challenge for managing diabetes due to the abundance of sweets. High sugar intake during these celebrations can lead to health complications, especially for India's large diabetic population. The article provides tips for a healthy festive season, including choosing healthier alternatives, portion control, staying active, and monitoring blood sugar levels.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UwfkqxH
via IFTTT

Read More

360 ONE Asset acquires stake in OneSource Specialty Pharma

360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undisclosed amount. The investment will support OneSource's innovation and global expansion plans. OneSource recently raised $95 million from other investors and is preparing to list its shares on stock exchanges.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QHh09nE
via IFTTT

Read More

How long sitting hours harm your health and how to avoid it

Incorporating movement and ergonomic adjustments into your routine can counteract the harmful effects of sitting. Small, consistent changes can significantly improve your overall well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rRe9Hq8
via IFTTT

Read More

About 18% of deaths in 2019 attributable to air pollution: ICMR study

A report by India's leading health research body found that air pollution caused 1.7 million deaths in 2019. This represents 18% of all deaths in the country that year. The primary cause of death was chronic obstructive pulmonary disease (COPD). The study identified industrial emissions, vehicular exhaust, and the burning of solid fuels as major contributors to air pollution.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6uS1Cwy
via IFTTT

Read More

Project SPECS of WHO will soon be implemented in Assam

The World Health Organization (WHO) is partnering with Sri Sankaradeva Nethralaya (SSDN) to launch the SPECS project in Assam, India. This pilot program aims to provide comprehensive eye care services, focusing on refractive errors, in three districts. The initiative will leverage SSDN's community-based approach and serve as a model for WHO's global efforts to improve eye health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fSTY5bm
via IFTTT

Read More

Wockhardt chairman seeks GST exemption for antibiotics discovered in India

Wockhardt founder sought GST exemption for antibiotics discovered in India. He said this will make the drugs more affordable. The statement was made at an event to celebrate the scientific completion of the first indigenously developed antibiotic Nafithromycin. Nafithromycin is the first macrolide antibiotic in 30 years for community-acquired bacterial pneumonia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/l5WrHTC
via IFTTT

Read More

High pollution may boost demand for respiratory drugs

"The respiratory market shows the normal seasonal trend for the anti-asthma and cough and cold segment," said Sheetal Sapale, VP, commercial, Pharmarack. "There were fewer reported cases in October 2024 compared to October 2023, hence there is de-growth in the market. The market peaks in December and January and then gradually subsides as winter loses its intensity," Sapale said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qt0vgsj
via IFTTT

Read More

Covid shots: Parents seek vaccine courts to ensure 'swift' justice

Parents of children who allegedly died from COVID-19 vaccine side effects are demanding justice and transparency in public health policies. They are calling for faster legal proceedings and a revamped system for reporting adverse events following immunization.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3HOrCEA
via IFTTT

Read More

Tired eyes? Try these 7 yoga poses for better vision naturally

These yoga asanas can help relax the eyes, strengthen eye muscles, and improve vision naturally. Regular practice, combined with a healthy lifestyle, can yield lasting benefits.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iUm4y0A
via IFTTT

Read More

Glenmark to focus on becoming branded company, says Glenn Saldanha

Glenmark Pharmaceuticals, having navigated recent challenges, is shifting its focus to branded products for higher profit margins. The company, aiming for a 12%-15% growth rate, divested its active pharmaceutical ingredient business to concentrate on branded pharmaceuticals, particularly in respiratory, dermatology, and oncology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FkqJe5o
via IFTTT

Read More

Biocon Biologics looks to trim $300 million debt in 1 year

Biocon Biologics plans to reduce its acquisition debt by $300 million over the next year. The company recently refinanced $1.1 billion in debt, providing more financial flexibility. Biocon aims to capitalize on the growing insulin market, with plans to double its insulin production capacity in Malaysia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VUW7gHT
via IFTTT

Read More

Supreme Court asks Zydus Lifesciences to approach Delhi HC over ban on selling breast cancer drug Sigrima

The Supreme Court has instructed Zydus Lifesciences to approach the Delhi High Court. Zydus is seeking relief from an order that prevents the sale of its breast cancer drug, Sigrima. Swiss pharmaceutical giant, Roche, alleges that Sigrima is similar to its own cancer drug. Roche requested the court to prohibit Zydus from selling Sigrima.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bCA6GZF
via IFTTT

Read More

Morning walks in high pollution: Safe or risky? How to stay active safely

While morning walks are often associated with numerous health benefits, they may not be safe during periods of high air pollution. By adapting your routine and staying informed about air quality, you can maintain an active lifestyle without risking your well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZhMrECV
via IFTTT

Read More

Dr Reddy's, FDC recall products in US for manufacturing issues

Dr Reddy's Laboratories and FDC Ltd issued voluntary recalls for medications in the US market due to manufacturing defects. Dr Reddy's recalled lots of Morphine Sulfate extended-release tablets due to failed impurity specifications, while FDC Ltd recalled Timolol Maleate ophthalmic solution due to defective containers hindering solution dispensing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vgHbkZK
via IFTTT

Read More

Menopause is hot: How celebrities and startups are transforming women's health

Menopause is having a moment, with celebrities and entrepreneurs capitalizing on the growing global market for menopause-related products and services. Indian women are also seeking solutions, leading to a surge in femtech startups offering everything from supplements and digital platforms to community support, aiming to break the taboo surrounding menopause.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/10N7xs9
via IFTTT

Read More

Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

Telangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the past year. This resulted in over 140 new projects. These projects include pharmaceutical manufacturing, R&D centers, and vaccine production. International companies are partnering with Indian businesses. The government expects these investments to create thousands of jobs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OPGcH5
via IFTTT

Read More

6 health benefits of drinking black coffee without sugar every day

Black coffee is a simple, calorie-free beverage with numerous health advantages. By skipping sugar, it becomes a powerhouse of nutrients and compounds that promote overall wellness. Here are six key benefits of drinking black coffee without sugar:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XEmecAI
via IFTTT

Read More

Diabetes too serious to be left to medical professionals only: Jitendra Singh

India is tackling its diabetes epidemic head-on. At the 52nd Annual Conference of the Research Society for the Study of Diabetes in India, experts stressed the need for public-private partnerships to address the disease affecting over 10 crore Indians.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5lqofW8
via IFTTT

Read More

7 surprising ways to use tea beyond drinking you didn't know about

Discover 7 surprising ways to use tea beyond just drinking! From reducing puffy eyes and fighting dandruff to deodorizing your home and repelling pests, these creative tea hacks will transform your routine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/S0XVsA3
via IFTTT

Read More

Want to add beetroot to your diet? Here are 7 healthy & colorful recipes for every meal

Beetroot is a nutrient-packed vegetable known for its rich color and health benefits. Here are seven delicious and healthy beetroot recipes to enjoy throughout the day.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/f9ZbEgi
via IFTTT

Read More

India has the highest number of diabetic people in the world, even more than China: Report

A new study reveals that over 800 million adults worldwide have diabetes. India leads the world with 212 million cases, followed by China with 148 million. The US has 42 million cases. The global diabetes rate has doubled since 1990. The study used data from over 140 million people across more than 1,000 studies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fbr1clT
via IFTTT

Read More

US-based AptarGroup breaks ground for new pharma plant in Taloja, near Mumbai

AptarGroup held a groundbreaking ceremony for a new pharmaceutical plant in Taloja, India. The facility expands AptarGroup's presence in the region. The plant will produce pressurized metered dose inhaler valves, breath-actuated devices, and single-dose nasal sprays. The company is exploring acquisitions to expand its drug delivery offerings.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FVuA4em
via IFTTT

Read More

Pharma market sees 6.1% growth in October despite subdued volumes

Amongst the top 10 therapies that contribute to more than 90% of the Indian pharma market, price drove growth in the cardiac segment. The anti-hypertensives, which account for almost 50% of the cardiac segment, is experiencing stagnated volume growth. Lipid-lowering drugs and platelet aggregation inhibitors have shown a relatively higher growth to help boost the cardiac segment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9gUHqbF
via IFTTT

Read More

Neem or curry leaves for healthier hair: Which works better?

Neem and curry leaves are popular natural ingredients for hair care, each offering unique benefits. Neem is known for its powerful antifungal and antibacterial properties, while curry leaves are rich in nutrients that strengthen and promote hair growth. Here’s a comparison to help you decide which might be better for your hair needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uiPE9JK
via IFTTT

Read More

Diabetes and heart health: Acting early

Type 2 diabetes significantly elevates the risk of heart disease, making individuals more susceptible to heart attacks, strokes, and heart failure. Early management is crucial, focusing on blood sugar control, blood pressure and cholesterol management, weight loss, and lifestyle modifications. This proactive approach can provide long-term heart health benefits, known as the "legacy effect."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ylBWEub
via IFTTT

Read More

Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsules

Alembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. These capsules, available in strengths of 120 mg to 360 mg, are designed to treat hypertension and manage angina. This approval grants Alembic access to an estimated market valued at USD 105.3 million annually.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yXOLMB6
via IFTTT

Read More

TA Associates to acquire majority stake in Vee Healthtek for $250 m

US private equity firm TA Associates is set to acquire a majority stake in Vee Healthtek, an Indian revenue cycle management firm, for $250 million. The deal marks TA's entry into India's RCM market and its second investment in the country's healthcare IT sector.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/R51ofd2
via IFTTT

Read More

Winter superfoods: 8 dry fruits and seeds to eat, their benefits, and ideal portions

Discover 8 dry fruits and seeds to boost your health this winter. Learn their benefits and the ideal servings for enhanced immunity, energy, and overall well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wKAbOS9
via IFTTT

Read More

Medical devices industry welcomes government's Rs 500-crore scheme

India's medical device industry is celebrating a new ₹500 crore government scheme designed to boost domestic manufacturing and reduce reliance on imports. The scheme will fund key initiatives such as manufacturing essential components, developing shared infrastructure, and supporting clinical studies, ultimately aiming to position India as a global leader in medical technology.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/twC7jDc
via IFTTT

Read More

Hashimoto's disease explained: Arjun Kapoor's battle, symptoms, and risks

Arjun Kapoor opens up about his struggle with Hashimoto’s disease, an autoimmune disorder affecting the thyroid. This slideshow explores the symptoms, risk factors, and what the condition entails for Kapoor.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/q15MALr
via IFTTT

Read More

Which weight loss method is most effective: Fasting, early eating, or fewer meals?

This research compares three popular weight-loss methods: intermittent fasting, eating earlier in the day, and consuming fewer meals. All methods show similar results, so choose the one that fits your lifestyle.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FDoWMLq
via IFTTT

Read More

Labour Ministry enters into MoU with Cygnus Ujala to enhance employability in the healthcare sector

The Ministry of Labour and Employment has partnered with Cygnus Ujala to boost healthcare job opportunities on the National Career Service (NCS) portal. This collaboration aims to add 25 lakh vacancies, focusing on Tier II and Tier III cities, with an emphasis on women's employment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ik1GdsX
via IFTTT

Read More

NPPA asks companies to cut prices of three cancer drugs post tax relief

In a move aimed at providing relief to cancer patients, the National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to reduce the maximum retail price (MRP) of three crucial cancer drugs. This directive follows the government's decision to exempt Trastuzumab Deruxtecan, Osimertinib, and Durvalumab from Customs duty and reduce GST rates on these medications.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7QJvgN8
via IFTTT

Read More

Medanta enters O&M for 750 bed super specialty hospital in New Delhi; to invest Rs 600 crore

Global Health, the company behind Medanta hospitals, has partnered with Dr. Narayan Dutt Shirmali Foundation to manage a new 750-bed super specialty hospital in Pitampura, New Delhi. The hospital, expected to open in four years, represents a Rs. 600 crore investment for Medanta and will offer a wide range of specialized medical services.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mX7YhRp
via IFTTT

Read More

OmniActive Health acquires botanical ingredients company ENovate Biolife

OmniActive Health Technologies, a Mumbai-based nutraceutical company, has acquired ENovate Biolife, a developer of botanical ingredients. This acquisition, funded through internal accruals, marks OmniActive's second strategic expansion. OmniActive aims to double its revenue to ₹2,000 crores within the next 5 to 6 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5NkcLRy
via IFTTT

Read More

Health groups raise concerns over patents for rare disease drugs

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue that these monopolies, like the one held by Roche for the spinal muscular atrophy drug Risdiplam, restrict access to affordable medication.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/i1HIR4y
via IFTTT

Read More

Venus Remedies gets GMP approval for pre-filled syringe facility

Indian pharmaceutical company Venus Remedies received a significant approval from the Malaysian authorities. The company's Baddi facility, equipped with advanced robotic technology, met the stringent quality standards for producing pre-filled syringes. This recognition paves the way for Venus Remedies to expand its global presence and provide critical medications to more countries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mJBNakw
via IFTTT

Read More

CDSCO may regulate health supplements to stem unapproved claims by firms

A government panel in India is proposing stricter regulations on health claims made by supplement manufacturers. The panel suggests shifting control from the food safety authority to the drug regulator, aiming to curb exaggerated claims related to disease treatment or risk reduction.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ichOSme
via IFTTT

Read More

US firm Alkomex to expand R&D footprint in India

Global pharmaceutical company Alkomex GBN is expanding its research and development operations into India. The company has appointed nutraceuticals expert Dr. Sanjay Agrawal as Scientific Advisor to lead these efforts. Based in Ahmedabad, Dr. Agrawal will oversee research and strategic initiatives, integrating Indian research into Alkomex's global operations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/O0euwlI
via IFTTT

Read More

FSSAI sets stricter rule for antibiotics in food items

"If enforced strictly, the regulations will ensure safer food products for consumers by setting stricter residue and contaminant limits across a variety of food items and help in dealing with antimicrobial resistance," said George Cheriyan, working president of Consumers Protection Association (CPA). The FSSAI has also prohibited the use of antibiotics during honey production and reset the limit of the chemicals ochratoxin A and deoxynivalenol in wheat, wheat bran, barley, rye and coffee.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Z6CwgT3
via IFTTT

Read More

Bajra roti or wheat roti? Which is better for health and weight loss?

Choosing bajra roti over wheat can be a great step toward better health and well-being. Here are the key benefits of choosing bajra roti over wheat for a healthier lifestyle.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/H0mS6M3
via IFTTT

Read More

Dr Reddy's recalls over 3.3 lakh bottles of generic medication in US: USFDA

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets in the US due to manufacturing issues. The recall is due to the presence of an impurity above FDA limits. The recall affects 30 mg, 60 mg, and 90 mg strengths, with the affected lot produced in India. The recall was initiated on October 9, 2023.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DIbUnKx
via IFTTT

Read More

Apollo Hospitals announces Rs 1,625 crore expansion in Mumbai and Lucknow

Apollo Hospitals announces a major expansion plan in Mumbai and Lucknow with a total investment of Rs 1625 crore over the next four years. The expansion, involving a 500-bed facility in Worli and a 200-bed extension in Lucknow, will be funded through internal accruals and debt financing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gVjTe08
via IFTTT

Read More

From fish to seeds: 5 excellent sources of Omega-3 fats for a healthier diet

Omega-3 fatty acids are essential fats that play a crucial role in maintaining heart health, supporting brain function, and reducing inflammation. While fatty fish are well-known sources, there are several other foods you can include in your diet to ensure you’re getting enough omega-3s. Here are five excellent sources to consider:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7aJrhny
via IFTTT

Read More

Suven, Cohance aim to double combined business revenue to Rs 6,000 cr by FY29

Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and inorganic growth. The merger has received NSE and BSE approvals, with a shareholders meeting scheduled for November 28, 2024. The combined entity will focus on pharma CDMO, specialty chemicals CDMO, and APIs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ITczxfL
via IFTTT

Read More

Govt to recast Insacog as Covid cases decline

The Indian government is considering restructuring Insacog, the consortium monitoring genomic variations in SARS-CoV-2, due to the decline in new Covid-19 cases and reduced testing frequency. Experts aim to determine whether to continue extensive sequencing or streamline it to fewer laboratories based on current needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GVuWKcm
via IFTTT

Read More

Yatharth Hospital to acquire 60% stake in Faridabad-based facility

Yatharth Hospital and Trauma Care Services has greenlit the acquisition of a 60% stake in a yet-to-be-operational 400-bed hospital in Faridabad valued at Rs 152 crore. This move, alongside acquiring a super speciality hospital in Model Town, Delhi, aims to bolster its presence in the Delhi-NCR region.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3utniv4
via IFTTT

Read More

SumeetSSG to invest Rs 1,600 cr in Maharashtra; bags emergency medical service project

Medical emergency service provider SumeetSSG will invest Rs 1,600 crore in Maharashtra to implement the MEMS 108 Ambulance Project, introducing advanced ambulance fleets with specialised medical equipment. The ten-year project, valued at Rs 14,000 crore, aims to enhance healthcare infrastructure and emergency response services across the state.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/982qPQt
via IFTTT

Read More

Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA

Biocon Biologics' drug substance facility in Bengaluru has been classified by the USFDA as voluntary action indicated after a cGMP inspection conducted in February 2024. The classification means that while some objections were noted, no regulatory action is recommended. The facility is responsible for supplying rh-Insulin drug substance to the US.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/A8l4LIK
via IFTTT

Read More

Cipla Q2 hit by seasonal chill, but investors need not worry

Cipla's September-quarter performance saw a 5.6% increase in consolidated net sales and a 15% rise in net profit despite slow seasonal growth in the anti-infectives category. The company expects a resurgence in growth due to seasonal respiratory illnesses and plans to address supply challenges and facility remediations in upcoming quarters.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uPDmSRM
via IFTTT

Read More

Fortis Healthcare gets CCI nod to acquire additional stake in Agilus Diagnostics for Rs 1,780 cr

The Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in Agilus Diagnostics, raising its total share to 89.2%. Additionally, CCI has greenlit the merger of Diliigent Power into DB Power and the reorganisation of Decore Thermal Power.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bQkLmIr
via IFTTT

Read More

Lyfius Pharma Penicillin-G plant inaugurated by PM Modi

Prime Minister Narendra Modi virtually inaugurated Lyfius Pharma's Penicillin-G plant in Kakinada, Andhra Pradesh, with a production capacity of 15,000 MT. The Rs 2,500 crore investment under the PLI Scheme aims to boost domestic manufacturing, reduce import dependency, and support 'Atmanirbhar Bharat' in establishing India as a global pharmaceutical hub.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zJ14kOU
via IFTTT

Read More

Govt asks manufacturers to cut price of 3 anti-cancer drugs

The government has directed manufacturers to lower prices of Trastuzumab, Osimertinib, and Durvalumab after exempting them from customs duty and reducing GST. This measure aims to ensure affordable anti-cancer drugs for consumers. Companies must update and report new prices to authorities and dealers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L8xRb4u
via IFTTT

Read More

PM Modi to launch, inaugurate multiple health sector projects worth over Rs 12,850 cr today

On the occasion of Dhanvantari Jayanti and 9th Ayurveda Day, Prime Minister Narendra Modi will launch, inaugurate and lay the foundation stone of multiple projects related to the health sector worth around Rs 12,850 crore on Tuesday at the All India Institute of Ayurveda (AIIA) in the national capital.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9oFv5Ei
via IFTTT

Read More

Dr Reddy's launches medication to treat chronic constipation

Dr Reddy's Laboratories has launched BixiBat, a new drug for chronic constipation in India. It is the first company to receive approval from the CDSCO for Elobixibat. The drug works by increasing bile acid concentration in the colon, promoting bowel movements. Clinical studies showed promising results. Shares of the company went up by 0.84 percent.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bViqB0G
via IFTTT

Read More

NCIL developing indigenous dialysis machine in collaboration with NIT Silchar

Nephro Care India Limited, in collaboration with NIT, Silchar, is developing an AI-enabled smart haemodialysis machine with a grant from West Bengal's Department of Science and Technology. This prototype aims to slash costs by up to 75%, making renal care more affordable and accessible, especially in rural areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qiAbKfX
via IFTTT

Read More

Could a Rs 72 lakh drug cost just Rs 3,000? A 24-year-old's courtroom revelation

A 24-year-old SMA patient in Kerala High Court revealed that Risdiplam, a crucial SMA drug, could be locally produced for Rs 3,000 annually compared to the current Rs 72 lakh. Highlighting the need for local manufacturing, the petition challenges the sufficiency of the Indian Health Ministry's financial aid and crowdfunding efforts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/x9huOws
via IFTTT

Read More

Piramal Pharma deploying USD 85 mn capex this fiscal: Nandini Piramal

Piramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD 30 million in the first half. Part of the funds will be for domestic use and some for the US. The company aims to reach USD 2 billion in revenue by FY30.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ySeLq6I
via IFTTT

Read More

Big chase for a cancer drug: The urgent need for affordable Keytruda alternatives

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, Indian companies are developing more affordable versions. Efforts are also focused on expanding indications and improving financial access.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Qq2VPOL
via IFTTT

Read More

Abhay HealthTech acquires MNP Healthcare to expand footprint in OTC segment

Abhay HealthTech has acquired MNP Healthcare to expand its OTC consumer healthcare sector. The deal includes MNP's brands, products, people, and manufacturing facilities. MNP Healthcare's directors will join Abhay HealthTech's advisory board. This acquisition enhances Abhay HealthTech's portfolio in areas like rapid testing kits, hygiene, skincare, supplements, women and baby care, and children wellness.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ArwHT2D
via IFTTT

Read More

Calcium, Vitamin D3 tablets, 47 others fail CDSCO's quality check: Check if your medication is safe?

The Central Drugs Standard Control Organisation (CDSCO) identified 49 drugs failing quality tests in its September report. Among these are commonly prescribed antibiotics, supplements, and pain relievers. The report also flagged four products, including popular calcium and prostate treatments, as “spurious,” manufactured by unverified companies. CDSCO’s ongoing efforts, which involved sampling 3,000 drug batches in September alone, are aimed at minimizing non-standard drugs in the market, ensuring the safety of public health through rigorous monthly monitoring.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/e8En12y
via IFTTT

Read More

Why technology alone can't fix India’s big healthcare divide

India's healthcare gap can't be bridged by technology alone; infrastructure and human resources are essential. Rural areas face severe deficiencies in medical facilities and professionals. Affordability and awareness also present major challenges, requiring comprehensive investment and public health campaigns to address these deep-rooted issues.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EHO6oPx
via IFTTT

Read More

Want glowing skin? Include these 5 drinks in your diet

Get a radiant, healthy glow by adding these five skin-loving drinks to your daily routine. From green tea to beet juice, each boosts hydration and revitalizes skin.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lT5mbIt
via IFTTT

Read More

Pharma bodies flag risks of refurbished medical gear imports

Medical device manufacturers are urging India's health minister to revoke the policy allowing unchecked import of refurbished medical devices like CT scanners and MRI machines. They argue this poses risks to patient safety and jeopardizes investments made under the Make in India initiative. They seek stricter regulations to ensure compliance with the National Medical Devices Policy 2023.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5DHFV8I
via IFTTT

Read More

Weight-loss drugs didn't curb health costs within two years, data show

U.S. health insurance claims analysis shows that two years after starting Novo Nordisk's Wegovy or similar GLP-1 drugs, annual medical costs for obese patients increased by 46% to $18,507, with no reduction in obesity-related medical events compared to a control group. These high costs concern employers and government officials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9WsZrNp
via IFTTT

Read More

Mankind Pharma completes Rs 13,768 cr BSV acquisition

Mankind Pharma has completed the acquisition of Bharat Serums and Vaccines Ltd for Rs 13,768 crore. This acquisition strengthens Mankind Pharma's position in the Indian women's health and fertility drug market. The transaction aligns with Mankind's strategy to access high entry barrier products and complex R&D platforms, promising accelerated growth and expanded market access.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8TzXQpi
via IFTTT

Read More

McDonald's E. Coli outbreak: Symptoms, source, and when to get medical help

An E. coli outbreak linked to McDonald's Quarter Pounders has left one person dead and 49 others ill. Find out its symptoms, likely sources of contamination, and when to seek medical help.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QI19TLX
via IFTTT

Read More

Zydus Lifesciences gets WHO prequalification for Typhoid Vi conjugate vaccine

Zydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV. Eligible for UN procurement, the vaccine targets 6-month to 65-year-olds and addresses high typhoid incidence in India, Africa, and Southeast Asia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LPqGtRs
via IFTTT

Read More

GST reduction will make insurance little affordable for customers, says Department of Finance Joint Secy

The Department of Finance's Joint Secretary stated that a reduction in Goods and Services Tax (GST) could make insurance more affordable for customers. Following requests for the removal of GST on term life and health insurance premiums, a Group of Ministers (GoM) met to discuss potential exemptions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ybhCFUe
via IFTTT

Read More

Manipal HealthMap acquires iGenetic Diagnostics

Manipal HealthMap has fully acquired Mumbai-based iGenetic Diagnostics to enhance its diagnostic services in key markets such as Maharashtra, Madhya Pradesh, and Karnataka. The acquisition aims to establish over 200 centers by 2027, contributing to a more integrated diagnostic services network across India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/X6xgpTu
via IFTTT

Read More

8 eco-friendly tips to combat air pollution during Diwali

Diwali is a time of celebration, but it can also lead to increased air pollution. By adopting eco-friendly practices, we can enjoy the festivities while protecting our environment and health. Here are eight effective ways to combat air pollution this Diwali.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MKibS6Y
via IFTTT

Read More

Diabetes, cardiac drugs market grows over 3x in 10 years

India's cardiac and anti-diabetes drugs market has surged over threefold in the past decade, reaching ₹30,000 crore and ₹17,000 crore respectively. Innovative medicines and loss of patents have driven growth, with several brands now contributing significantly to market turnover.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VGmJgX1
via IFTTT

Read More

The ‘A’ and ‘B’ of diabetes: When less is more

HbA1c testing is crucial for diabetes management as it reflects average blood sugar levels over three months, unlike single-point fasting or postprandial tests. Regular testing and weight management can significantly reduce diabetes complications, yet many people in India neglect this vital check, exacerbating health risks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5vKZ3M2
via IFTTT

Read More

Alembic Pharma gets USFDA nod for generic hypertension treatment capsules

Alembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of 120 mg, 180 mg, and 240 mg to treat hypertension and chronic stable angina. These capsules are therapeutically equivalent to Allergan Sales LLC’s Dilacor XR, with an estimated market size of USD 28.2 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LRUItQN
via IFTTT

Read More

Indian pharma firms trail global peers in R&D, innovation, and talent metrics: FAST India-IIFL Securities

Indian pharmaceutical firms lag behind global companies in R&D intensity, PhD employee proportion, and patents and publications per billion USD revenue, the report said. Global firms produce significantly more patents and publications, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gAqY2wJ
via IFTTT

Read More

India's bioeconomy valued at $150 bn, innovation holds key to global leadership: BIRAC MD

India's biotechnology sector, valued at USD 150 billion, is expanding, yet innovation and product development potential remain untapped. BIRAC supports startup growth and R&D investment to elevate India's bioeconomy, though increased private-sector investment and streamlined regulatory processes are essential for global leadership in biotech.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5v48bkq
via IFTTT

Read More

GST on term life insurance premium, senior citizen's health coverage likely to be exempt

The Group of Ministers (GoM) is likely to recommend exempting Goods and Services Tax (GST) on term life insurance premiums and health insurance premiums paid by senior citizens. During a recent meeting, the GoM decided to exempt GST for health insurance coverage up to Rs 5 lakh for individuals (excluding seniors), while premiums above this threshold will still attract 18% GST. Currently, 18% GST applies to life insurance premiums as well.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZSewcEy
via IFTTT

Read More

7 common post-meal mistakes that can ruin your digestion

By being aware of these post-meal habits and making adjustments, you can support better digestion and enhance your overall health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zkXF35h
via IFTTT

Read More

Sparsh Hospitals lines up expansion plans

The Sparsh Group of Hospitals, led by Sharan Shivaraj Patil, plans to expand by investing ₹350-400 crore in two new Bengaluru hospitals and ₹150 crore in an R&D centre. They aim to raise equity funds in fiscal 2026. The company remains profitable and will add some debt for expansion.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vCcwypE
via IFTTT

Read More

Stop believing these 6 nutritional myths: Get the facts!

Nutritional myths can often mislead us, making it difficult to make informed choices about our diets. Here are seven common nutritional myths that you should stop believing:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Q1sN9BJ
via IFTTT

Read More

Alia Bhatt opens up about ADHD: Key insights & symptoms you should know

Alia Bhatt opens up about her ADHD journey, sharing how it affects her daily life and moments of peace. She discusses her diagnosis, common symptoms, and how it shapes her experiences on set and with her daughter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0th9LrM
via IFTTT

Read More

NCLAT closes insolvency proceedings against JHL as Max Healthcare settles creditor's claims

The National Company Law Appellate Tribunal (NCLAT) has ended insolvency proceedings against Jaypee Healthcare, as financial creditors' dues were settled by Max Healthcare with a Rs 1,035.29 crore payment. The CIRP was initiated by NCLT following a petition by JC Flowers Asset Reconstruction Ltd.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3MacBfH
via IFTTT

Read More

Pleasure profits: Sex stimulants show enhanced performance

Sales of sex stimulants and rejuvenators in India have surged by 17% over the past year, with significant gains in sildenafil and tadalafil brands like Viagra and Cialis. This growth is attributed to decreased inhibitions and increased openness to sexual wellness, supported by accessible knowledge and healthcare professionals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rQaHV3i
via IFTTT

Read More

US, Europe key export destinations for drug formulations, biologicals, surgical goods

India’s exports of surgical goods, drug formulations, and biologicals are gaining ground in US and European markets. The sector has shown substantial growth during April-August 2024. Exports to the US, UK, and other countries highlight India as a prominent global supplier of high-quality pharmaceutical and surgical products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/p6XGMbe
via IFTTT

Read More

Intermittent fasting: Who should avoid this popular eating pattern?

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OK56W3H
via IFTTT

Read More

Piyush Goyal holds meeting to address concerns of pharmaceutical exporters

Union Commerce Minister Piyush Goyal engaged with key pharmaceutical industry stakeholders, including the IMDA's General Secretary, to tackle challenges faced by pharmaceutical exporters and enhance India's position in the global market. The meeting highlighted collaborative efforts to address hurdles and maintain competitiveness in quality and pricing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DTUwWGv
via IFTTT

Read More

SeaLink, promoter plan to sell majority stake in Surya Hospital

Private equity firm SeaLink Capital Partners and the Surya Children's Medicare promoter plan to sell their stakes in western India's largest children's hospital chain. Valued at ₹1,000-1,200 crore, JM Financial is managing the process, targeting global PE firms and leading Indian hospital chains for the acquisition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SA4KlzD
via IFTTT

Read More

From Code to Care: How AI and hyperautomation can change patient care in India

Indian healthcare is being transformed by hyperautomation and other digital technologies. These advancements are improving patient care, reducing costs, and streamlining processes. Successful implementation requires collaboration between healthcare providers, government agencies, and tech companies. The shift towards digitisation is expected to overcome inefficiencies and create a more sustainable healthcare system for the future.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Km4h8vD
via IFTTT

Read More

Strides Pharma's OneSource raises Rs 801 crore in pre-listing round

OneSource Specialty Pharma, an associate of Strides Pharma, secured Rs. 801 crore from investors including HBM Healthcare Investments and WhiteOak Capital. With these funds, OneSource will reduce debt and enhance its manufacturing capabilities. The company aims to list its shares by March 2025 and targets being debt-free by FY26. Strides shareholders will benefit significantly from this transaction.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MIlZQHG
via IFTTT

Read More

Government seeks dismissal of plea on Covishield deaths, Supreme Court to hear on November 26

The Supreme Court is hearing a plea from parents demanding an investigation into their daughters' deaths allegedly caused by Covishield vaccine. The government argues vaccination was voluntary and widely affirmed. The parents accuse the government of misleading the public and insufficiently addressing adverse effects.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y681QIE
via IFTTT

Read More

Cipla, Alkem Laboratories in final lap to buy SMT

Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest their holdings. “They could retain about 15-20% stake post the deal,” said one of the persons cited above. Morgan Stanley PE Asia and Samara Capital collectively own 49% of SMT, while Kotak Pre-IPO Opportunities Fund has a 6% stake. The Kotadias own the remaining 45%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/O743IdY
via IFTTT

Read More

Delhi HC allows Zydus Lifesciences to sell breast cancer drug Sigrima

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations of it being similar to Roche's Perjeta. The court invalidated an earlier restraint order, noting no patent infringement by Zydus.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eTvDiMN
via IFTTT

Read More

Marengo Asia eyes rights issue, stake sale to fund growth

Marengo Asia Healthcare plans to expand its bed capacity to 3,000 by 2026 and may involve an external investor. The platform has acquired multiple hospitals and is exploring further acquisitions and asset-light operation contracts. Currently, it operates with a 1,700-bed capacity and aims to reach an EBITDA margin above 20% in the next 12 to 18 months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OBAsU2b
via IFTTT

Read More

Turmeric for weight loss: 5 easy ways to shed pounds naturally

Turmeric, a golden spice known for its anti-inflammatory and antioxidant properties, can be a helpful addition to your weight loss routine. Rich in curcumin, turmeric boosts metabolism, aids digestion, and helps detoxify the body. Here are five ways to incorporate turmeric into your daily routine for effective weight management:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XE6l8bs
via IFTTT

Read More

11 countries already recognise Indian pharmacopoeia as their standard: DCGI Rajeev Raghuvanshi

India is supplying drugs, vaccines, and medical devices to over 200 countries, with 11 countries recognizing Indian pharmacopoeia standards. The regulatory system is advanced, approving around 100 global clinical trials annually, and India's vaccine regulatory framework meets WHO global standards, bolstering its position as a significant international vaccine supplier.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dXGZcMU
via IFTTT

Read More

7 compelling reasons to add sweet potatoes to your diet

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8d3jB6O
via IFTTT

Read More

India reaffirmed its role as the pharmacy of the world during COVID: JP Nadda at International Conference of Drug Regulatory Authorities

Union Minister of Chemicals and Fertilisers JP Nadda, during his address at the 19th International Conference of Drug Regulatory Authorities (ICDRA), hailed India's crucial role during the Covid-19 pandemic and how the country is emerging as a global leader in health resilience and innovation, thereby reaffirming its position as the 'pharmacy of the world.'

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uVCrfJL
via IFTTT

Read More

More health packages focused on elderly care likely to be added to AB-PMJAY

The National Health Authority is set to extend the Ayushman Bharat scheme to include those aged 70 and above, benefiting around six crore citizens. The scheme will offer expanded health packages focusing on geriatric care and provide free treatment up to Rs 5 lakh annually.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9QOyAK3
via IFTTT

Read More

Glenmark arm recalls products in US for manufacturing issues

Glenmark Pharmaceuticals is recalling 45,504 bottles of Ryaltris Nasal Spray and 11,568 tubes of Ciclopirox Gel in the US due to manufacturing defects, including a clogged dip tube and broken tube seals. The USFDA has classified the recalls as Class II and Class III respectively.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L0QbREr
via IFTTT

Read More

Star Health says it received $68k ransom demand after data leak

Star Health, India's largest health insurer, received a $68,000 ransom demand following a significant customer data leak. The hacker, using Telegram and a website, exposed sensitive information. The company has taken legal action and is cooperating with Indian cyber security authorities to identify the perpetrator.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RDM3cOY
via IFTTT

Read More

PE firms queue up for Novartis' Indian arm

The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and is also expected to bid. Alkem Labs is also in the fray. Novartis India has a market capitalisation of around ?2,500 crore though bids are likely to value it lower, as per those in the know. Non-binding bids are due later this month.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dqzuBg
via IFTTT

Read More

India's top drug regulator meets WHO standards for functional vaccine regulatory system

A WHO-led team reviewed India's vaccine regulatory system from September 16 to 20. The system was declared functional by meeting WHO's global standards and benchmarks. India's regulatory system has retained maturity level 3 with top marks in several functions. This achievement highlights India's significant role in the global pharmaceutical industry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oDfeaIQ
via IFTTT

Read More

No easy access for morning-after pill?

The government is considering a proposal requiring prescriptions for emergency contraception pills due to concerns about misuse and health risks. Experts argue that limiting access could result in more unwanted pregnancies, emphasizing the need for balanced information rather than restrictive measures.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NbQCxj8
via IFTTT

Read More

Zydus gets US nod for schizophrenia generic medicine

Zydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are used to treat schizophrenia and schizoaffective disorders. The approval covers strengths of 1.5 mg, 3 mg, 6 mg, and 9 mg, with production set at the SEZ facility in Ahmedabad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DfHrg9w
via IFTTT

Read More

Rural households' out-of-pocket spend on hospitalisation stay Rs 4,129/yr, urban Rs 5,290: Govt Report

A government survey reported that the average out-of-pocket medical expenses for hospitalization over the past year were Rs 4,129 in rural areas and Rs 5,290 in urban areas. For non-hospitalization treatments in the last 30 days, the costs averaged Rs 539 in rural households and Rs 606 in urban ones.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rSTCspQ
via IFTTT

Read More

QR code must for all vaccines to check fakes

The Indian government has mandated QR codes on all vaccines to combat counterfeiting and ensure authenticity. The Drug Controller General of India indicated an aggressive campaign against non-compliance, supported by strict enforcement and prosecution measures. Future expansions include QR code implementation on more products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cGsxv9R
via IFTTT

Read More

Govt waives testing of cough syrups for export to key markets

India has waived off mandatory testing of cough syrups for export to countries like USA, UK, and EU if their regulatory authorities have approved the manufacturing plants. This change follows earlier requirements due to contamination concerns in Gambia and Uzbekistan. The Directorate General of Foreign Trade updated the export policy to reflect this exemption for specific approvals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aTiEJl7
via IFTTT

Read More

Aurigene reports promising phase-1 data for its CAR-T therapy against myeloma

Aurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with multiple myeloma. All patients achieved clinical response, with no high-grade safety events reported. The Indian drug regulator has approved the commencement of a phase-2 trial.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Hhc72ZO
via IFTTT

Read More

Are you making these 5 common fitness mistakes?

By being mindful of these common mistakes, you can enhance your fitness routine and work towards achieving your health goals more effectively.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hERP7Ys
via IFTTT

Read More

Ayushman Bharat to expand coverage for elderly healthcare to include Alzheimer's, Cancer, and more

Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) will expand to cover treatments for conditions like Alzheimer's, dementia, heart failure, and cancer in the elderly. This move aims to help six crore senior citizens, offering crucial healthcare access. A committee of medical experts is developing new packages to address these needs effectively.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mR6rBJA
via IFTTT

Read More

7 flavorful foods rich in healthy fats for a healthier you

Here are seven foods packed with healthy fats that can enhance your diet:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hTOampW
via IFTTT

Read More

Garmin, Apollo Hospitals join hands for health monitoring & wellness

Garmin and Apollo HealthAxis have partnered to bring advanced fitness tracking and personalized wellness programs to India. Garmin fitness trackers will be integrated with Apollo Health Plans, offering health monitoring and AI-powered health prediction. The collaboration also aims to improve healthcare in rural areas by combining Garmin's technology with Apollo's expertise.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qCc7tVU
via IFTTT

Read More

Pharma companies seek more teeth for agencies to fight fakes

India's leading drug makers, through the Indian Pharmaceutical Alliance, have petitioned the Supreme Court to enable police and drug inspectors to investigate and prosecute counterfeit drug manufacturers. They argue that without proper enforcement and protection, the prevalence of counterfeit drugs has increased, affecting public health and India's global pharmaceutical reputation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aIjZTn7
via IFTTT

Read More

What lifestyle changes can help you stay cancer-free?

By adopting a healthier lifestyle and being proactive about your health, you can make a meaningful impact on your overall well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/joznMk1
via IFTTT

Read More

ICMR to study efficacy of Metformin, Inositol in PCOS treatment

India's ICMR will study the efficacy of Metformin and Inositol drugs in improving fertility and birth outcomes in PCOS women. Despite widespread use, evidence on their effectiveness is limited, especially in the Indian context. The multi-centre study will address this knowledge gap.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1fchZ23
via IFTTT

Read More

Detox dangers: Why you should reconsider

Detoxes lack scientific backing and may be unsafe due to poor regulation. Experts recommend consulting a healthcare professional for personalized, sustainable health solutions instead of relying on detox products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8KVyroN
via IFTTT

Read More

Govt may mandate QR codes to check fake cancer drugs

The Indian government plans to require QR codes on all cancer drugs. This step aims to prevent counterfeit medicines and ensure drug authenticity. The Drugs Technical Advisory Board has agreed to the proposal. An amendment to the Drugs Rules, 1945, is necessary before implementation. This move follows earlier efforts to add barcodes on top 300 drug brands.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zzn8X2y
via IFTTT

Read More

Lupin subsidiary acquires 9 brands South African firm

Lupin's subsidiary, in partnership with ImpiloVest, has acquired nine brands from MNI in South Africa, enhancing its portfolio in complementary and alternative medicines. The acquired brands address various health issues, aligning with Lupin's commitment to holistic and sustainable healthcare solutions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/o6Pi3Za
via IFTTT

Read More

Quick access to key HIV drug hinges on waiver of local clinical trials: Experts

Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, have non-exclusive, royalty-free licenses to produce generic versions. They must apply for waivers to supply the drug locally and in 120 low- and middle-income countries. Approval from the drug regulator is crucial.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35L7eW2
via IFTTT

Read More

Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug Lenacapavir

Emcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for HIV prevention and treatment. This royalty-free agreement focuses on increasing access to the drug in 120 countries, especially resource-limited nations. Emcure aims to provide high-quality, low-cost HIV medication to improve health outcomes globally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0jB2cKg
via IFTTT

Read More

CCI clears Rs 13,630 cr Mankind Pharma acquisition of Bharat Serums

The Competition Commission of India (CCI) has approved Mankind Pharma's ₹13,630-crore acquisition of Bharat Serums and Vaccines. This acquisition will strengthen Mankind's position in the Indian women's health and fertility drug market. Mankind Pharma and Bharat Serums both specialize in pharmaceutical formulations and healthcare products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WZEcsIU
via IFTTT

Read More

Dr Reddy's enters voluntary licensing deal with Gilead for long-acting HIV drug

Dr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agreement includes developing Lenacapavir for both treatment and potential prevention of HIV. This collaboration aims to make this advanced treatment accessible in regions with high HIV burdens.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HZbqXu5
via IFTTT

Read More

CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal

The Competition Commission of India has approved Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines. This acquisition, which includes a 100% stake, advances Mankind Pharma's position in the women's health and fertility drug market and grants access to critical care products with established R&D platforms.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bRyXsdU
via IFTTT

Read More

Government looking to tweak regulatory norms for MedTech, pharma sectors: Niti Aayog's VK Paul

The Indian government is considering regulatory revisions for the MedTech and pharma sectors and has sought input from the industry. Niti Aayog member VK Paul highlighted the need to update the regulatory framework to support advancements in medical technology and pharma, aiming for enhanced exports and innovation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QyVP3OY
via IFTTT

Read More

Life support withdrawal for terminally ill: IMA flags concerns, says it will put doctors under stress

The Indian Medical Association has expressed concerns over new guidelines that put the responsibility of deciding on life support withdrawal on doctors. The draft suggests a dual-board system and family consent for terminally ill patients. This aims to help families make informed choices but may stress doctors.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qgv3rJ8
via IFTTT

Read More

Venus Remedies get market authorisations for two cancer drugs from Morocco, Philippines

Venus Remedies Ltd has received marketing authorisations for two key oncology drugs, carboplatin and bortezomib, from Morocco and the Philippines. These approvals are part of the company's strategy to expand its oncology range and meet the growing global demand for cancer treatments, strengthening its position in Southeast Asia and Africa.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sqeOPVY
via IFTTT

Read More

Linking spurious drugs with legitimate manufacturers has severe reputational, financial impact: IPA

The Indian Pharmaceutical Alliance (IPA) has called for a clear distinction between spurious and sub-standard drugs following a CDSCO report listing over 50 products as 'not of standard quality'. Major drug firms like Sun Pharma and Glenmark assert that flagged medicines are counterfeits, not their products. IPA emphasizes the need to protect India's reputation as a reliable medicine supplier.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AB0WwEI
via IFTTT

Read More

Regulatory, policy reforms crucial for future of India's pharma R&D: Report

India's regulatory and policy reforms are crucial for the future of pharmaceutical R&D, streamlining approval processes and strengthening IP protections. Despite significant transformation, challenges like inadequate drug regulation capacity and high compliance costs hinder growth. The report suggests promoting India as a hub for pharmaceutical research and development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sWd74oz
via IFTTT

Read More

Health ministry comes up with new draft guidelines on passive euthanasia

The Union Health Ministry's draft guidelines on passive euthanasia suggest doctors should make considered decisions on withdrawing life support for terminally ill patients based on specific conditions. The guidelines aim to ensure decisions are in the patient's best interests, considering factors like brainstem death and informed refusal by the patient or their kin.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kKW1Tel
via IFTTT

Read More

Monkeypox in India: Key do's and don'ts you need to follow

The Health Ministry's guidelines for Monkeypox in India stress isolation, testing, and public awareness while urging prompt reporting of cases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QJ9s0SU
via IFTTT

Read More

Medical bills in India are rapidly becoming bigger, reveals new index

The ACKO India Health Insurance Index 2024 reveals a 14% annual rise in healthcare costs, with 62% of expenses paid out of pocket. Delhi leads in kidney disease claims, while Kolkata and Mumbai see high heart disease claims. It emphasised the need for improved health coverage to protect individuals from unexpected health crises.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xY9Z6tD
via IFTTT

Read More

EQT to exit AGS Health, eyes $750 million valuation

Swedish fund EQT Partners is set to sell its five-year-old investment in US-based healthcare IT services firm AGS Health, aiming for a valuation of $750 million-$780 million. The sale process, managed by JP Morgan and Bank of America, will launch early next year. AGS Health provides revenue cycle management solutions and employs 12,000 people across multiple locations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F8vrpdQ
via IFTTT

Read More

Want to make India a reliable pharmacy of world, says Secretary Department of Pharmaceuticals

The Indian pharmaceutical industry is emerging as a crucial part of the economy, driven by the success of the Make in India initiative and the Production-Linked Incentive scheme. The sector has seen significant growth in exports and global interest, with many Contract Research, Development, and Manufacturing Organisations establishing operations in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LVwZ8TC
via IFTTT

Read More

Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore merger

Sequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and integrated capabilities across the global pharmaceutical market. The merger will expand Sequent's capital base and is expected to enhance marketing presence, facilitate backward integration, and create procurement synergies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Epe2y4F
via IFTTT

Read More

Carlyle Group portfolio companies in advanced talks for a potential merger

Sequent Scientific, which is in animal health business, posted revenue of around Rs 1,400 crore in FY24. It had earnings before interest, tax, depreciation and amortisation of Rs 100 crore. It has seven manufacturing sites in India, Spain, Brazil and Turkey. Viyash was founded in February 2019 by Hari Babu, formerly the chief operating officer of the world's largest generic drug maker, Mylan, now known as Viatris. Viyash posted FY24 revenue of Rs 1,400 crore with ebitda at Rs 150 crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HFoZOyh
via IFTTT

Read More

Suspended eye drops not intended to replace glasses, says Entod CEO

Mumbai-based Entod Pharmaceuticals clarified that its eye drop PresVu is not intended to replace reading glasses for presbyopia. This follows the Indian drug regulator's suspension of its manufacture and sale due to unapproved claims. The company's CEO acknowledged the regulator's decision, stating the eye drop is a therapeutic option.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sl7raSE
via IFTTT

Read More

Paracetamol to pantop: CDSCO finds over 50 sub-standard drugs. Check full list of medicines

The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The report highlights concerns with various medications such as calcium and vitamin D3 supplements, anti-diabetes pills, and high blood pressure medicines. Some pharmaceutical companies have denied responsibility, claiming the drugs are spurious.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/K2c5TqS
via IFTTT

Read More

IHH Health eyes acquisitions to grow business: CEO Prem Kumar Nair

IHH Healthcare plans to double its bed capacity in India to 10,000 beds over the next 4-5 years through brownfield expansion and acquisitions. The group aims to be among the top three healthcare providers in India, expanding into tier-2 cities while maintaining dual brands Fortis and Gleneagles.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Uit8jk2
via IFTTT

Read More

Piramal Pharma targets to double revenue in 5 years

Piramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO business. The company plans strategic investments to enhance capabilities in various segments and is also focusing on reducing debt. Currently, CDMO contributes significantly to its revenue.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FScmLoT
via IFTTT

Read More

Health expenditure share against GDP increases from 1.13% in FY15 to 1.84% in FY22

The government health expenditure in India has increased from 1.13% of GDP in 2014-15 to 1.84% in 2021-22, according to the National Health Account estimates. Government spending on healthcare has tripled, while out-of-pocket expenses have significantly decreased, reflecting positive progress towards financial protection and Universal Health Coverage.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2de1tLo
via IFTTT

Read More

Testing of drugs from some nations eased

The government has decided to reduce the frequency of testing for drugs imported from certain countries, provided their samples have not failed quality tests in the past five years. Random sampling will be conducted periodically, and any failed samples will lead to increased testing. New sources must undergo compulsory testing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lav8F4d
via IFTTT

Read More

Govt considers random testing of imported medical devices

The government is planning to enhance the quality monitoring of imported medical devices by implementing a risk-based approach. This will involve random sampling for quality tests and full cargo testing for critical diagnostic kits. A guidance document has been issued for port officers to assist in this process, emphasizing the importance of public health safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nEqgRje
via IFTTT

Read More

Common diabetic drug Metformin may become a wonder drug to keep people young; Study finds promising results in monkeys

A recent study has shown that metformin, a diabetes medication, may slow ageing in monkeys by preserving cognitive function and delaying tissue ageing. Conducted by Guanghui Liu's team at the Chinese Academy of Sciences, the research suggests potential benefits for human ageing. Further trials are planned to explore these findings in humans.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Fi3xVRW
via IFTTT

Read More

PM Modi to inaugurate Penicillin-G plant in Andhra Pradesh, reviving India's antibiotic production

Prime Minister Narendra Modi is expected to inaugurate a new Penicillin-G plant in Andhra Pradesh, marking the revival of domestic production after three decades. Hyderabad-based Aurobindo Pharma will produce 300 metric tonnes annually, reducing India's dependency on China for this crucial antibiotic component.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F3BlHUY
via IFTTT

Read More

PM Modi pledges USD 7.5 million to Quad Cancer Moonshot to battle cervical cancer

Prime Minister Narendra Modi announced a USD 7.5 million support for cervical cancer sampling kits, detection kits, and vaccines at the Cancer Moonshot event in Delaware. He emphasized India's integrated approach to cancer prevention and treatment, and highlighted India's cost-effective screening program and new AI-driven treatment protocols.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/92JkA7l
via IFTTT

Read More

Quad Cancer Moonshot: PM Modi announces USD 7.5 million support to fight cervical cancer

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MxuDk9G
via IFTTT

Read More

No observations by US FDA during plant inspection: DRL

Dr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing Practice (GMP) inspection of its integrated product development organization in Bachupally, Hyderabad, with zero observations. The company shared this update in a stock exchange filing on Friday, highlighting compliance with regulatory standards.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ilcP7UJ
via IFTTT

Read More

Torrent Pharma gets an observation from USFDA for Pithampur plant

Torrent Pharmaceuticals announced that the USFDA issued a Form 483 with one procedural observation after inspecting its Pithampur manufacturing facility. The inspection took place from September 16-20. Torrent Pharma will respond within the prescribed timeframe and collaborate closely with the USFDA to address the observation. Shares of Torrent Pharma rose by 2.97% on BSE.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wWrzmD0
via IFTTT

Read More

Suven Pharmaceuticals names Vivek Sharma as executive chairman

Suven Pharma, backed by Advent International, has appointed Vivek Sharma as the new executive chairman effective September 20. Sharma brings extensive experience in managing CDMO businesses and will focus on global expansion. The former chairman, Annaswamy Vaidheesh, transitions to vice-chair of Suven’s Advisory council.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wBuPF5J
via IFTTT

Read More

Aster DM Health, Quality CARE inching closer to a merger deal

The merger between Aster DM Healthcare and Quality CARE India is nearing completion, with a deal expected by month-end. The merged entity, Aster DM Quality CARE, will become India's second-largest listed hospital chain. Blackstone and TPG will hold significant stakes but without additional control rights.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Wp8eDx
via IFTTT

Read More

Aurobindo to acquire 49 pc stake in GLS Pharma for Rs 22.5 cr

Aurobindo Pharma Ltd will acquire the remaining 49% stake in GLS Pharma Ltd for Rs 22.5 crore, making it a wholly-owned subsidiary. The acquisition of 5,90,361 equity shares is expected to be completed by December 31, 2024. GLS Pharma specializes in oncology products, including chemotherapy treatments.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sNP7QcY
via IFTTT

Read More

Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market

Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The drug, approved for various gastrointestinal conditions, will be marketed as Lupivon in 10 mg and 20 mg strengths. This agreement aims to enhance Lupin's gastroenterology portfolio and address unmet patient needs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mlbgFur
via IFTTT

Read More

Dispute with Sanofi settled, Panacea scrip soars to over 3-yr high

Panacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involved Panacea's claim that Sanofi's Shan6 vaccine infringed on its EasySix patent. Sanofi agreed not to market the infringing product and withdrew its opposition to Panacea's patent amendment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/adExQTr
via IFTTT

Read More

Combating counterfeit protein supplements: How genuine brands can lead the fight

The Indian protein supplement market faces challenges with nearly 70% of products containing incorrect information or harmful contaminants. The FSSAI has announced stricter regulations to ensure product safety and accuracy. Industry leaders emphasize the importance of transparency, quality control, and consumer education to combat counterfeit products and maintain trust.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ntfkhqp
via IFTTT

Read More

Panacea, Sanofi settle patent litigation over hexavalent vaccine

Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its opposition to Panacea's patent. Panacea will forgo claims for damages. The Delhi High Court disposed of the suit on September 13, 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yIdrseM
via IFTTT

Read More

Panacea Biotec, Sanofi settle patent infringement suit

Panacea Biotec has settled a patent infringement dispute with Sanofi Healthcare India regarding its fully liquid hexavalent vaccine, EasySix. Sanofi agreed not to launch its Shan6 vaccine in India and will withdraw oppositions against Panacea's patent amendment application. The Delhi High Court disposed of the suit on September 13, 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8htzvEp
via IFTTT

Read More

Polymed lines up ₹750 crore for expansion, buys over two years

The company last month raised ₹1,000 crore through qualified institutional placement (QIP) and has ₹150 crore as free cash flow to fund its growth plans. Polymed makes disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets. About two-thirds of sales come from infusion therapy products. The company spends 2% of revenue on R&D.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6mYKvcz
via IFTTT

Read More

Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad

Laurus Labs has inaugurated a new R&D facility at IKP Knowledge Park near Hyderabad, investing Rs 250 crore. The 200,000 square foot center will support their CDMO business and create over 800 jobs. The facility aims to develop innovative solutions for unmet medical needs, according to CEO Satyanarayana Chava.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MkSy8au
via IFTTT

Read More

30-30-30 method for weight loss: What is it and does it really work?

The 30-30-30 method involves a high-protein breakfast, followed by 30 minutes of exercise. It boosts metabolism, aids weight loss, and is easy to maintain.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jTOntgC
via IFTTT

Read More

How intravenous drips of vitamins are becoming popular and why doctors flag them as unnecessary

A person associated with a wellness centre in Gurgaon says on condition of anonymity that the vitamin IV “therapy” is gaining traction and the footfall the centre is getting is increasing every month. “The number of people opting for IV vitamins has gone up by 30-40% over last year,” he says, adding, “We offer packages depending on what one wants. A screening is done by our in-house doctor and then a cocktail is decided.” Instead of popping multivitamin tablets, why do people opt for intravenous drips? “When vitamins are taken orally, the absorption rate is 20-50%. However, it is 90-100% when it is given intravenously,” the person says. It is sought by people in the metros, he adds.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MbpW7Gf
via IFTTT

Read More

Drug sales get a monsoon twist in August

Liver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related illnesses during the monsoon season. The Indian pharmaceutical market saw a 6.3% growth year-over-year, with gastrointestinal and anti-diabetic medications performing strongly in both sales value and volume.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EyuMvXq
via IFTTT

Read More

Ayushman Bharat enrollment for senior citizens to start in a week

Enrollment for senior citizens aged 70 and above under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) will begin soon. Initially launching as a pilot program, eligible seniors can apply through the Ayushman mobile app or PMJAY portal. The scheme offers free health insurance coverage of up to Rs 5 lakh annually on a family basis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yDRJhuM
via IFTTT

Read More

Healthcare, manufacturing sector to benefit most from Fed rate cuts: Motilal Oswal

As the U.S. Federal Reserve's anticipated rate cut approaches, a report by Motilal Oswal suggests that the healthcare and manufacturing sectors are expected to benefit the most. Healthcare is projected to be the fastest-growing sector, while manufacturing may see technological advancements. Challenges remain for BFS, retail, and hi-tech industries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Rd8yeFZ
via IFTTT

Read More

Alkem joins $3 bn race for JB Chem as Torrent pauses talks

Alkem Laboratories, India's fifth-largest branded pharmaceutical company, is vying for JB Chemicals and Pharmaceuticals as KKR looks to sell. Torrent Pharmaceuticals has exited negotiations over valuation differences. If successful, this will be Alkem's largest acquisition, enhancing its presence in the chronic segment and potentially moving it to fourth place in the domestic formulations market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WFzC6X1
via IFTTT

Read More

Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector

Biocon Chairperson Kiran Mazumdar-Shaw urges increased investment in research and development to drive innovation and intellectual property culture. Speaking at Global Bio-India 2024, she highlights India's potential as a global bio-innovation hub, emphasizing its scientific talent and technological capabilities. She also underscores the importance of biotechnology in healthcare and agriculture.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sRV9xg0
via IFTTT

Read More

DNA Wellness to invest Rs 200 cr to set up over 100 cervical cancer screening labs

Ahmedabad-based DNA Wellness will invest Rs 200 crore to establish over 100 cervical cancer screening labs across India by 2027. The company has exclusive rights to conduct the DNA Ploidy Test, developed by the British Columbia Cancer Research Agency. The first CERViSure lab has been launched in Ahmedabad, with plans for more labs in Gujarat by October 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mSZtNxk
via IFTTT

Read More

Durex makes India condom push for women, rural consumers

Reckitt Benckiser, the world's largest condom maker, is shifting its focus in India to target women and rural consumers. With changing attitudes towards female pleasure and a rise in condom use among Indian women, Reckitt is reformulating products and launching new marketing campaigns. The company faces challenges with distribution, pricing, and conservative societal norms but sees significant growth potential in India's expanding market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2gnU5Zl
via IFTTT

Read More

DCGI suspends nod to Entod's new eye drops over unapproved 'claims'

India's drug regulator has suspended Entod Pharmaceuticals' permission to manufacture and sell PresVu Eye Drops. The company did not obtain clearance for its claim that the drops reduce dependency on reading glasses for presbyopia. Entod plans to challenge the suspension in court, asserting that their clinical trials demonstrated efficacy and safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dh4IsHS
via IFTTT

Read More

Bharat Biotech inks pact with Alopexx for anti-microbial vaccine

Bharat Biotech has partnered with Alopexx, Inc. to co-develop and commercialize the anti-microbial vaccine AV0328 in India and other low-income countries. The collaboration aims to address antimicrobial resistance through vaccination, with Alopexx receiving upfront and milestone payments, as well as royalties on future sales in licensed territories.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tMWp0zS
via IFTTT

Read More

Jaggery or sugar: Which sweetener is better for your health?

Jaggery is healthier due to its nutrient content, lower glycemic index, liver detox benefits, digestive aid, immune boost, and minimal processing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y3QicrD
via IFTTT

Read More

8 essential plants you should have for a mosquito-free home

Looking for natural ways to keep mosquitoes at bay? Incorporating mosquito-repelling plants into your garden or home can be both effective and aesthetically pleasing. Here are eight plants that not only enhance your outdoor space but also help keep pesky insects away.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/N7XljdL
via IFTTT

Read More

US animal health major Zoetis expands GCC in Hyderabad, to add 300 jobs by 2025

Zoetis, the world's largest producer of pet and livestock medicine, is expanding its global capability centre in Hyderabad. The centre will add around 300 technology jobs by next year and support the company's global operations using advanced technology tools. This expansion aims to leverage Hyderabad's tech talent pool and life-science ecosystem.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qSGvzW4
via IFTTT

Read More

Plant for production of Penicillin G & Clavulanic acid to start soon: Department of Pharmaceuticals

The Department of Pharmaceuticals has announced that India will soon start producing Clavulanic Acid, a key ingredient in the antibiotic Augmentin. This move is part of the Production Linked Incentive scheme aimed at reducing dependency on foreign imports and boosting local manufacturing of essential bulk drugs like Penicillin G and Clavulanic Acid.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zKT5GCB
via IFTTT

Read More

Johnson & Johnson told to pay ₹35 lakh each as compensation to hip implant victims

The National Consumer Disputes Redressal Commission has ordered Johnson & Johnson to pay ₹35 lakh in compensation to each patient affected by a faulty hip implant. The commission also mandated an interest of 6% per annum on the compensation from the complaint filing date. The payment must be made within two months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TkCvjgN
via IFTTT

Read More

Fortis seeks CCI nod to buy 31.52% more in diagnostics subsidiary Agilus

Fortis Healthcare has sought approval from the Competition Commission of India to acquire an additional 31.52% stake in its diagnostics arm, Agilus, raising its shareholding to 89.2%. The deal, valued at ₹1,780 crore, involves buying stakes from private equity players. Additionally, Aquilo House Pte seeks approval to acquire a 26.47% stake in Aavas Financiers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/d1TNWH4
via IFTTT

Read More

EQT to acquire ChrysCap-owned healthcare BPO GeBBS

Swedish Private Equity fund EQT has acquired GeBBS Healthcare Solutions from ChrysCapital for approximately $860-870 million. GeBBS, a provider of revenue cycle management services, has seen significant growth under ChrysCapital's ownership. The acquisition aligns with EQT's focus on healthcare technology and aims to further accelerate GeBBS' growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3FzQaBW
via IFTTT

Read More

Looking to lose weight? Try these 6 bedtime yoga poses!

These poses, done consistently, can aid in weight loss by reducing stress, improving digestion, and promoting better sleep.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/d9Ytn05
via IFTTT

Read More

Building muscle mass: Why the growing lure of protein supplements is worrying health experts

The protein revolution is transforming diets across India, with many turning to supplements to meet their nutritional needs. This trend is driving a booming industry but also raising concerns about the indiscriminate use of protein powders. Experts advocate for balanced diets and caution against over-reliance on marketed products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VioM3mr
via IFTTT

Read More

7 bad habits to avoid after 40 for a healthier life

Here are seven bad habits to quit after 40 to improve health and well-being:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dRDKClo
via IFTTT

Read More

Wockhardt says acted as per laws, denies Congress' charges over affiliate rental payments to Sebi chief

Wockhardt has refuted allegations of conflict of interest and corruption made by the Congress party against SEBI chairperson Madhabi Puri Buch. The claims relate to rental payments by Carol Info Service, an affiliate of Wockhardt, which is involved in multiple cases with SEBI, including insider trading. Wockhardt termed the allegations as baseless and misleading.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/rUGg3dR
via IFTTT

Read More

India takes tiny steps back from its China dependency

India is striving to reduce its dependency on China for pharmaceutical raw materials by promoting domestic production through a Production-Linked Incentive scheme. Companies like Kinvan and Aurobindo Pharma are stepping up to produce essential components locally, aiming for self-sufficiency in the pharma sector, especially highlighted during the Covid pandemic.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/n1yklau
via IFTTT

Read More

Novo Nordisk not yet ready to bring in popular obesity, diabetes injectables

Novo Nordisk's launch of weight-loss and diabetes drugs Wegovy and Ozempic in India hinges on resolving supply issues. The company is scaling up production and may consider local fill-finish options. Currently, the injectable forms are not approved in India, leading to high demand in grey markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xHSkP0l
via IFTTT

Read More

Strides gets USFDA nod for Theophylline extended-release tablets

Strides Pharma Science Ltd announced that its subsidiary has received approval from the USFDA for its generic version of Theophylline extended-release tablets, used to manage chronic asthma and other respiratory conditions. The tablets, available in 300 mg and 450 mg doses, will be produced at their Bengaluru facility and have a market size of around USD 11.5 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dDlAq1O
via IFTTT

Read More

India starts making key API clavulanic acid

India has begun producing clavulanic acid, a key ingredient in the antibiotic Augmentin, reducing its reliance on China for APIs. Mumbai-based Kinvan is leading this initiative, with plans to scale up production to 300 metric tons by the end of the year. This move aligns with India's production-linked incentive scheme.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/x8qYw7W
via IFTTT

Read More

Alembic Pharma gets USFDA nod for generic product

Alembic Pharmaceuticals has received approval from the USFDA to market Albendazole Tablets USP (200 mg), a generic drug for treating infections caused by worms. The tablets are equivalent to Impax Laboratories' Albenza and are used for conditions like parenchymal neurocysticercosis and cystic hydatid disease. Alembic Pharma shares rose 2.79% on Thursday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tl8GQaC
via IFTTT

Read More

Need to strike fine balance between making hospitals secure and accessible: AIIMS-Delhi director

Dr. M Srinivas, Director of AIIMS-Delhi, has highlighted the need for balancing hospital security and accessibility amid demands for a safer work environment following the RG Kar rape-murder case. He underlined the importance of improving infrastructure and working conditions for medical professionals while ensuring patient care remains a priority.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SGpDgnU
via IFTTT

Read More

Potential outbreak-causing dangerous viruses found in China’s fur animals

Scientists have discovered novel and potentially dangerous viruses in raccoon dogs, mink, and other fur-farmed animals in China. The study found 125 virus species, including 36 novel ones, with 39 posing a high risk of crossing the species barrier. This highlights the need for better virus surveillance in fur-animal farming.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/aUwg9mO
via IFTTT

Read More

EQT set to acquire BPO GeBBS from ChrysCapital

Swedish private equity fund EQT is set to acquire Los Angeles-based healthcare BPO company GeBBS Healthcare Solutions for about $870 million. The deal, which outbid Hillhouse Investment, is expected to be signed soon. GeBBS, founded in 2005, employs 14,000 workers globally and competes with major firms like Wipro and IBM.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ncdX7e0
via IFTTT

Read More

Lactose intolerant? 6 top non-dairy calcium sources for healthy bones

Here are 6 non-dairy sources of calcium that are great for maintaining healthy bones:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BAuIFPY
via IFTTT

Read More

Natco Pharma acquires 40 million shares in eGenesis Inc

Natco Pharma's Canadian subsidiary has acquired 40 million shares in eGenesis Inc. for USD 8 million. eGenesis is a biotechnology company developing human-compatible organs for transplant through xenotransplantation. This investment aims to support eGenesis' pioneering work in kidney, liver, and heart transplants, potentially addressing the global transplant shortage.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0X8Lkc5
via IFTTT

Read More

No link between mobile phones and brain cancer, WHO-backed study says

A World Health Organization-commissioned review has found no link between mobile phone use and an increased risk of brain cancer. The study, which analyzed data from 63 studies between 1994 and 2022, showed no rise in brain cancer cases despite the surge in wireless technology usage.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ry2vViu
via IFTTT

Read More

Cipla's vice-chairman MK Hamied resigns citing age and health, his son Kamil to join the board

Cipla's vice-chairman MK Hamied has resigned from the board due to age and health concerns, effective October 29, 2024. His son Kamil Hamied will join as a non-executive director from November 1, 2024. Cipla also appointed Adil Zainulbhai and Abhijit Joshi as additional directors starting September 3, 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/h0PqOS9
via IFTTT

Read More

Cipla's MK Hamied resigns from the company due to health reasons

Cipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resignation will be effective from the close of business hours on October 29, 2024. In a letter to employees, Hamied expressed pride in his tenure and confidence in Cipla's future success.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bBGapOy
via IFTTT

Read More

Mankind: How Meerut brothers built India's 4th largest pharma firm

Mankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly funded by debt, aims to strengthen Mankind’s portfolio. The Juneja brothers are confident in their strategy despite market concerns about integration and cost.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nbZ3jD2
via IFTTT

Read More

Mankind Pharma eyes ₹9,000 cr via debt to stitch BSV deal

The average blended cost of the debt is likely to be around 8.50% with the firm seeking to borrow money over one- to-five years, said three people familiar with the plans. "Bankers have already approached large mutual funds to place the debt, which will range from one year and may go up to five years looking at the demand," said one of the persons.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kcw4QbH
via IFTTT

Read More

Alkem inks licensing pact with Takeda to introduce Vonoprazan in India

Alkem Laboratories has entered into a patent licensing agreement with Takeda Pharmaceutical to market Vonoprazan in India. This medication is used to treat conditions like reflux esophagitis and various ulcers. This licensing deal will enhance Alkem's offerings in the gastrointestinal segment, according to CEO Vikas Gupta. The company's shares dropped 1.66% on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ulcrmtk
via IFTTT

Read More

How to control blood sugar naturally: 7 tips

Discover seven natural strategies to balance blood sugar levels, including increasing fiber intake, staying hydrated, exercising, and managing stress effectively.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/f0gCyh7
via IFTTT

Read More

Biocon unit gets USFDA nod for generic drug

Biocon Pharma has received approval of its ANDA for Sacubitril/Valsartan Tablets, in 24 mg/26 mg, 49 mg/51 mg and 97 mg/103 mg strengths, from the US Food and Drug Administration (USFDA), the company said in a regulatory filing. Sacubitril and valsartan combination is used to treat chronic heart failure in adults to help reduce the risk of death and hospitalisation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/u6aRht3
via IFTTT

Read More

AI-powered device successfully treats blood clot in a 28-year-old

A 28-year-old man with acute pulmonary thromboembolism was successfully treated at Sir Gangaram Hospital using an AI-powered device designed to remove blood clots accurately. The device prevents severe blood loss by targeting only clots. This method avoids the risks associated with conventional treatments like internal bleeding and repeated interventions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/weUABvg
via IFTTT

Read More

PCOS on the rise in young women: Are you at risk?

PCOS is increasingly affecting young women. Discover the key risk factors, symptoms, and management strategies to protect your health and well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ya7CcSh
via IFTTT

Read More

Sooji breakfast recipes: 5 healthy and easy options to try

Here are five healthy breakfast ideas using sooji (semolina):

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BVgCYqa
via IFTTT

Read More

Zydus Lifesciences gets warning letter from USFDA for its Jarod injectable unit

Zydus Lifesciences received a warning letter from the USFDA regarding its injectables manufacturing facility at Jarod, following an inspection in April 2024. The letter cites violations of cGMP regulations. Zydus must respond within 15 days and take remedial action. The warning limits new product launches, impacting business growth in the US market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ufi6SM5
via IFTTT

Read More

Zydus Lifesciences gets USFDA nod to market Scopolamine transdermal system

Zydus Lifesciences Ltd has received USFDA approval to market its Scopolamine transdermal system, which helps prevent nausea and vomiting under various conditions, including after surgery and due to motion sickness. The product, with a dosage of 1 mg/3 days, will be manufactured in Ahmedabad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kSlFUcB
via IFTTT

Read More

7 protein-packed dinners for healthy weight loss

These 7 high-protein dinner recipes, including grilled chicken salad, baked salmon, and quinoa bowls, are designed to help with weight loss by providing satisfying, nutrient-rich meals that support your goals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Wb5dFV0
via IFTTT

Read More

Monkeypox RT-PCR Test: A step-by-step guide for accurate results

Discover how to accurately use the Monkeypox RT-PCR test kit: from sample collection to handling and lab processing. Ensure reliable results with these essential steps.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cowmiuJ
via IFTTT

Read More

Listeria infection: Symptoms, source, and prevention

Over 50 hospitalized and 9 deaths reported in a major Listeria outbreak. Contaminated deli meats are linked to the outbreak. Learn about symptoms and safety tips.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7a5fupW
via IFTTT

Read More

Want to purify your blood? Try these 6 foods

Discover 6 natural foods that can help purify your blood, removing toxins and improving circulation. From beetroot to turmeric, these everyday ingredients support detoxification and enhance overall health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SuOZPnU
via IFTTT

Read More

Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, Japan

Biocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & Johnson to launch Bmab 1200, a biosimilar to Stelara, in Europe, the UK, Canada, and Japan. This deal resolves patent disputes and secures future market entry, pending regulatory approvals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31h8gKJ
via IFTTT

Read More

Indian pharma exporters feel pain on Bangladesh crisis

The political unrest and violence in Bangladesh are posing significant challenges for Indian pharmaceutical exporters, leading to stranded funds and concerns over financial stability. This situation threatens to impact medicine availability and healthcare services in Bangladesh. Despite the market's growth potential, many Indian companies are now hesitant to supply without advance payments, emphasising the importance of risk management in this unpredictable scenario.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VaBeDh5
via IFTTT

Read More

Hillhouse bids highest to buy healthcare BPO GeBBS from Chrys Cap for $870 mn

GeBBS Healthcare Solutions, a Los Angeles-based healthcare BPO firm, is nearing acquisition by Hillhouse Investment, which has offered about $870 million. The final decision is expected in two weeks as ChrysCapital holds another round of negotiations. The acquisition will potentially see industry veterans Gautam Barai and Gautam Narayan at the helm.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ac8Q2mK
via IFTTT

Read More

Sloth fever outbreak: Key facts on the deadly virus and should you be worried?

The Oropouche virus, also known as "sloth fever," is spreading in South America and the Caribbean. Transmitted by midges and mosquitoes, it causes symptoms similar to dengue and Zika, with no vaccine or specific treatment available.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Y175rKt
via IFTTT

Read More

Fairfax, Bain look to buy Gujarat's API Company Farmson

Canadian billionaire Prem Watsa's Fairfax Group and Bain Capital are in competition for a buyout of Farmson Basic Drugs, a leading API maker in India valued at ₹4,000 crore. Founded in 1969, Farmson is a major paracetamol manufacturer with a revenue of ₹1,750 crore in FY24. The company's concentrated focus on paracetamol production is a strength, but limited R&D poses challenges for diversification.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/euQimrX
via IFTTT

Read More